Pfizer Fined $106M Over Price Of Epilepsy Drug In UK
Pfizer Ltd. has been smacked with a record £84.2 million ($106 million) fine for charging the U.K.'s National Health Service excessive and unfair prices for an anti-epilepsy drug and ordered to...To view the full article, register now.
Already a subscriber? Click here to view full article